NIFTY 50▼25,014.60
-235.50 (-0.93%)
SENSEX▼81,688.45
-808.65 (-0.98%)
NIFTY BANK▼51,462.05
-383.15 (-0.74%)
TATA MOTORS▲930.75
5.05 (0.55%)
SUZLON ENERGY▼74.67
-1.08 (-1.43%)
TATA STEEL▼166.75
-0.23 (-0.14%)
INDIAN RAILWAY FINANCE CORP▲152.07
0.47 (0.31%)
TATA POWER▼466.65
-5.15 (-1.09%)
RAIL VIKAS NIGAM▼493.40
-16.10 (-3.16%)
VODAFONE IDEA▼9.79
-0.08 (-0.81%)
RELIANCE INDUSTRIES▼2,773.05
-40.90 (-1.45%)
INDIAN RENEWABLE ENERGY▼221.66
-1.66 (-0.74%)
ZOMATO▲275.30
6.30 (2.34%)
RELIANCE POWER▼50.95
-2.69 (-5.01%)
ADANI POWER▼642.10
-2.65 (-0.41%)
YES BANK▲21.95
0.09 (0.41%)
STATE BANK OF INDIA▲796.65
2.55 (0.32%)
NHPC▲93.17
0.21 (0.23%)
HDFC BANK▼1,657.65
-24.35 (-1.45%)
JIO FIN SERVICES LTD▼338.80
-6.80 (-1.97%)
OLA ELECTRIC MOBILITY LTD▼99.05
-0.21 (-0.21%)
BHARAT ELECTRONICS▼277.20
-1.50 (-0.54%)
INDIAN OIL CORP▼168.65
-2.68 (-1.56%)
ADANI PORT & SEZ▼1,413.70
-11.50 (-0.81%)
GTL INFRA▼2.31
-0.04 (-1.70%)
MRF▼1,33,408.75
-2695.60 (-1.98%)
JAIPRAKASH POWER VENTURES▼19.43
-0.67 (-3.33%)
INDIAN RAILWAY TOURISM CORP▼872.75
-13.65 (-1.54%)
AKUMS DRUGS AND PHARMA L Share Price
AKUMS
₹844.70-₹0.90 (-0.11%) TodayLast updated on 04 Oct, 2024 | 15:29 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹838.00 | Close₹845.60 |
Circuit range₹878.35 - ₹794.75 | Day range₹832.55 - ₹852.00 | Year range₹725.00 - ₹1,175.90 |
Volume81,243 | Avg. traded₹841.08 | Revenue (12m)₹0 Crs |
AKUMS DRUGS AND PHARMA LAkums Drugs and Pharmaceuticals Limited is an India-based pharmaceutical contract development and manufacturing company. It offers a comprehensive range of pharmaceutical products and services in India and overseas. It is focused on providing end-to-end product development and manufacturing solutions to its clients. Its segments include Contract Development and Manufacturing Operations (CDMO), Active Pharmaceutical Ingredient (API) and Branded and Generic formulations. CDMO segment includes the formulation research and development, preparation and regulatory filing of dossiers, manufacturing formulations on a contract basis, job work and testing services. API segment is engaged in the manufacture and sale of key starting materials, Intermediate and API products. Branded and Generic formulations segment is engaged in marketing and distribution of branded and generic pharmaceutical formulations. It has manufactured 4,146 commercialized formulations across over 60 dosage forms.
AKUMS DRUGS AND PHARMA L Key indicators
52 week high₹1,175.90 | 52 week low₹725.00 | P/E ratio |
P/B ratio4.48 | ROE50.47% | ROCE42.75% |
Dividend yield-- | Debt/Equity ratio0.47 | EPS8.77 |
Learn more
Featured in
Investment checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin26.27% | Net profit margin9.75% |
ROE50.47% | ROA6.77% |
ROCE42.75% |
Learn more
AKUMS DRUGS AND PHARMA L Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Oct 4 2024 | ₹838.00 | ₹836.55 | -1.07% |
Thu, Oct 3 2024 | ₹867.90 | ₹845.60 | -2.58% |
Tue, Oct 1 2024 | ₹843.40 | ₹868.00 | |
Mon, Sep 30 2024 | ₹832.95 | ₹835.85 | |
Fri, Sep 27 2024 | ₹835.00 | ₹832.60 | |
Thu, Sep 26 2024 | ₹835.20 | ₹831.75 | -0.45% |
Wed, Sep 25 2024 | ₹841.85 | ₹835.50 | -0.54% |
Tue, Sep 24 2024 | ₹856.25 | ₹840.00 | -1.90% |